Shares of AngioDynamics, Inc. (ANGO) were trading down nearly six percent on Wednesday morning after the company announced a wider loss for the fourth-quarter and full year 2024 outlook below analysts' view.
from RTT - Before the Bell https://ift.tt/zDXjfJG
via IFTTT
No comments:
Post a Comment